These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 21831908)
1. Galectin-2 expression is dependent on the rs7291467 polymorphism and acts as an inhibitor of arteriogenesis. van der Laan AM; Schirmer SH; de Vries MR; Koning JJ; Volger OL; Fledderus JO; Bastiaansen AJ; Hollander MR; Baggen JM; Koch KT; Baan J; Henriques JP; van der Schaaf RJ; Vis MM; Mebius RE; van der Pouw Kraan TC; Quax PH; Piek JJ; Horrevoets AJ; van Royen N Eur Heart J; 2012 May; 33(9):1076-84. PubMed ID: 21831908 [TBL] [Abstract][Full Text] [Related]
2. Interferon-beta signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice. Schirmer SH; Fledderus JO; Bot PT; Moerland PD; Hoefer IE; Baan J; Henriques JP; van der Schaaf RJ; Vis MM; Horrevoets AJ; Piek JJ; van Royen N Circ Res; 2008 May; 102(10):1286-94. PubMed ID: 18420941 [TBL] [Abstract][Full Text] [Related]
3. Galectin-2 induces a proinflammatory, anti-arteriogenic phenotype in monocytes and macrophages. Yıldırım C; Vogel DY; Hollander MR; Baggen JM; Fontijn RD; Nieuwenhuis S; Haverkamp A; de Vries MR; Quax PH; Garcia-Vallejo JJ; van der Laan AM; Dijkstra CD; van der Pouw Kraan TC; van Royen N; Horrevoets AJ PLoS One; 2015; 10(4):e0124347. PubMed ID: 25884209 [TBL] [Abstract][Full Text] [Related]
4. G-CSF induced arteriogenesis in humans: molecular insights into a randomized controlled trial. Meier P; Gloekler S; Oezdemir B; Indermuehle A; Traupe T; Vogel R; de Marchi S; Seiler C Curr Vasc Pharmacol; 2013 Jan; 11(1):38-46. PubMed ID: 23391421 [TBL] [Abstract][Full Text] [Related]
5. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Heil M; Ziegelhoeffer T; Wagner S; Fernández B; Helisch A; Martin S; Tribulova S; Kuziel WA; Bachmann G; Schaper W Circ Res; 2004 Mar; 94(5):671-7. PubMed ID: 14963007 [TBL] [Abstract][Full Text] [Related]
6. CD44 regulates arteriogenesis in mice and is differentially expressed in patients with poor and good collateralization. van Royen N; Voskuil M; Hoefer I; Jost M; de Graaf S; Hedwig F; Andert JP; Wormhoudt TA; Hua J; Hartmann S; Bode C; Buschmann I; Schaper W; van der Neut R; Piek JJ; Pals ST Circulation; 2004 Apr; 109(13):1647-52. PubMed ID: 15023889 [TBL] [Abstract][Full Text] [Related]
7. Stimulation of Collateral Vessel Growth by Inhibition of Galectin 2 in Mice Using a Single-Domain Llama-Derived Antibody. Hollander MR; Jansen MF; Hopman LHGA; Dolk E; van de Ven PM; Knaapen P; Horrevoets AJ; Lutgens E; van Royen N J Am Heart Assoc; 2019 Oct; 8(20):e012806. PubMed ID: 31594443 [TBL] [Abstract][Full Text] [Related]
8. [Mechanisms and potential of the therapeutic stimulation of arteriogenesis]. Schirmer SH; van Royen N; Laufs U; Böhm M Dtsch Med Wochenschr; 2009 Feb; 134(7):302-6. PubMed ID: 19197812 [TBL] [Abstract][Full Text] [Related]
9. MAb therapy against the IFN-α/β receptor subunit 1 stimulates arteriogenesis in a murine hindlimb ischaemia model without enhancing atherosclerotic burden. Teunissen PF; Boshuizen MC; Hollander MR; Biesbroek PS; van der Hoeven NW; Mol JQ; Gijbels MJ; van der Velden S; van der Pouw Kraan TC; Horrevoets AJ; de Winther MP; van Royen N Cardiovasc Res; 2015 Jul; 107(2):255-66. PubMed ID: 25935869 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of MCP-1 and leptin on collateral flow and arteriogenesis. Schirmer SH; Buschmann IR; Jost MM; Hoefer IE; Grundmann S; Andert JP; Ulusans S; Bode C; Piek JJ; van Royen N Cardiovasc Res; 2004 Nov; 64(2):356-64. PubMed ID: 15485696 [TBL] [Abstract][Full Text] [Related]
11. Involvement of the fibroblast growth factor system in adaptive and chemokine-induced arteriogenesis. Deindl E; Hoefer IE; Fernandez B; Barancik M; Heil M; Strniskova M; Schaper W Circ Res; 2003 Mar; 92(5):561-8. PubMed ID: 12600883 [TBL] [Abstract][Full Text] [Related]